Tesi sul tema "Biotechnology"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 saggi (tesi di laurea o di dottorato) per l'attività di ricerca sul tema "Biotechnology".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi le tesi di molte aree scientifiche e compila una bibliografia corretta.
Kara, Selin, Marco Berheide e Andreas Liese. "Reversibility of asymmetric catalyzed C–C bond formation by benzoylformate decarboxylase". Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2016. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-189019.
Testo completoDieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich
Kara, Selin, Marco Berheide e Andreas Liese. "Reversibility of asymmetric catalyzed C–C bond formation by benzoylformate decarboxylase". Royal Society of Chemistry, 2015. https://tud.qucosa.de/id/qucosa%3A29057.
Testo completoDieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
Hurets, H. M. "Environmental biotechnology". Thesis, Sumy State University, 2015. http://essuir.sumdu.edu.ua/handle/123456789/40374.
Testo completoZanger, Maggy. "Taking Biotechnology into the Classroom: Biotechnology Tissue Culture Workshop". College of Agriculture, University of Arizona (Tucson, AZ), 1991. http://hdl.handle.net/10150/295695.
Testo completoMisner, Scottie, Carol Curtis e Evelyn Whitmer. "Biotechnology and Food". College of Agriculture and Life Sciences, University of Arizona (Tucson, AZ), 2008. http://hdl.handle.net/10150/146433.
Testo completoRevision of 1999 title by Meer and Misner
A general definition of biotechnology is the use of a living organism or its products for commercial purpose. Today, biotechnology involves the use of recombinant DNA techniques to obtain desired qualities or products. This article addresses the importance and safety issue of biotechnology when it is used in food products.
Shanadi, Govind. "Hollywood representations of biotechnology /". view abstract or download file of text, 2007. http://proquest.umi.com/pqdweb?did=1421624771&sid=3&Fmt=2&clientId=11238&RQT=309&VName=PQD.
Testo completoDavies, Louise. "Global networks : biotechnology patentability". Thesis, Lancaster University, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.420627.
Testo completoRimmington, Anthony. "Biotechnology in the USSR". Thesis, University of Birmingham, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.544229.
Testo completoYurchenko, D. "3D bioprinting in biotechnology". Thesis, Sumy State University, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45875.
Testo completoKust, V., Наталія Миколаївна Усенко, Наталия Николаевна Усенко e Nataliia Mykolaivna Usenko. "Biotechnology in modern life". Thesis, Sumy State University, 2020. https://essuir.sumdu.edu.ua/handle/123456789/77979.
Testo completoAbreu, Sara Priscila Lopes de. "Collagenase for biotechnology applications". Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/15507.
Testo completoCollagen is an abundant protein in all animals and is the main component of numerous tissues, having also structural and regulatory roles. Collagen can be found in various numerous locations presenting specific functions, such as the establishment of the cellular shape, its strength and structural integrity, and is also involved in tissue maintenance. Moreover, collagen has an important role in the formation of the extracellular matrix of the connective tissue, by contributing to its physical properties. Collagenases are enzymes, more specifically metalloproteinases, with a zincbinding domain. These enzymes are able to digest the triple helical region of native collagen, cleaving its peptide bonds. In recent years, bacterial collagenases have been gaining interest for industry proposes, by offering a variety of applications. In the clinical area, collagenases are used as therapy for diseases associated with excessive deposition of collagen, as for example, in patients suffering from Dupuytren’s disease. The enzymes can also be used to help the debridement of wounds and burns, and also for cancer gene therapy applications. The objective of this work is the comparison and optimization of two methods of recombinant collagenase purification, evaluating which method provides the most cost-effective purification. For that purpose, a simple and high resolution method for purification of histidine-tagged recombinant protein was used. Immobilized metal ion affinity chromatography (IMAC) with a Ni Sepharose 6 Fast Flow, through a column HisTrap FF 1ml or in batch were used. Results obtained through protein quantification by densitometry technique, showed that the purification using a column has higher yield. By zimography was possible determine the gelagenolytic activity of ColAh, and was also possible quantify the collagenolytic activity of ColAh, using a synthetic peptide N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala (FALGA). Obtained results also showed that the obtained recombinant protein is stable to storage over time and when submitted to different temperatures (room temperature; 4°C; -20°C).
O colagénio é uma proteína abundante em todos os animais, exercendo funções estruturais e reguladoras. Está presente em diversos locais e executa funções específicas, nomeadamente na manutenção dos tecidos e na conservação da sua estrutura celular, da sua força e integridade estrutural. Possui uma elevada importância na formação da matriz extracelular do tecido conjuntivo ao contribuir para as suas propriedades físicas. Colagenases são enzimas, mais especificamente metaloproteinases, com um característico domínio de ligação a zinco característico Atualmente, as colagenases bacterianas possuem diversas aplicações industriais. Por exemplo, na clínica são utilizadas no tratamento de doenças associadas a acumulação excessiva de colagénio, como a Doença de Dupuytren, no desbridamento de queimaduras e feridas e também em terapia génica oncológica. O objetivo deste trabalho é a comparação e a otimização de dois métodos de purificação, para avaliar qual dos processos será mais rentável. Para tal, foi utilizado um método de purificação de proteínas recombinantes, que foram marcadas com histidinas, utilizando um método de cromatografia de afinidade com ião metálico imobilizado (IMAC). Para comparação, a purificação foi estabelecida utilizando um método em coluna, HisTrap FF e um método em batch. Os resultados obtidos através da quantificação de proteína, usando técnica de quantificação por densitometria demonstraram que a purificação quando realizada por coluna, apresenta maior rendimento. Através de ensaios realizados posteriormente foi possível demonstrar a atividade da ColAh por zimografia de gelatina, e quantificar a atividade colagenolitica contra o péptido sintético N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala (FALGPA). Os resultados também demonstram que a proteína recombinante apresentou estabilidade, quando armazenada ao longo do tempo, a diferentes temperaturas (temperatura ambiente; 4°C; -20°C).
Sivakumar, Gayathri. "Agricultural biotechnology and Indian newspapers". Thesis, Texas A&M University, 2004. http://hdl.handle.net/1969.1/1133.
Testo completoATTATHOM, Tipvadee. "Biotechnology for Insect Pest Control". 農学国際教育協力研究センター, 2004. http://hdl.handle.net/2237/8932.
Testo completoSteele, Frances A., of Western Sydney Nepean University, Faculty of Education e School of Teaching and Educational Studies. "Teaching biotechnology in NSW schools". THESIS_FE_TES_Steele_F.xml, 1999. http://handle.uws.edu.au:8081/1959.7/671.
Testo completoMaster of Education (Hons)
Reid-Henry, Simon. "Cuban biotechnology : an experimental milieu". Thesis, University of Cambridge, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.433036.
Testo completoCampbell, Moray James. "Novel membrane separations in biotechnology". Thesis, University of Kent, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.359337.
Testo completoAffaticati, P. E. "Engineering transketolase for industrial biotechnology". Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1557943/.
Testo completoSaghir, Mouris. "Commercialization strategies of biotechnology companies". Thesis, Massachusetts Institute of Technology, 1999. http://hdl.handle.net/1721.1/57763.
Testo completoIncludes bibliographical references (leaves 49-50).
In the biotechnology industry today, there are many business models for project commercialization. These models range from independent vertical integration to certain forms of collaboration with pharmaceutical companies to complete acquisitions of projects by the big pharmaceutical companies. In this thesis, we wanted to study commercialization strategies of several biotechnology companies. We wanted to investigate the rational for commercialization decisions and the consequence of these decisions on biotechnology firms'. Thus, we conducted interviews with either founders or senior managers of business development of nine biotechnology firms to address these issues. Our results demonstrate that biotechnology firms reluctantly enter partnership agreements with pharmaceutical companies. In addition, there are delays in the negotiation process before agreements are reached, which can have negative impact on biotechnology firms. Furthermore, concentration on core competencies and the presence of champions at the pharmaceutical partners are two essential elements of successful commercialization for biotechnology firms.
by Mouris Saghir.
S.M.
Steele, Frances A. "Teaching biotechnology in NSW schools". Thesis, View thesis View thesis, 1999. http://handle.uws.edu.au:8081/1959.7/671.
Testo completoSteele, Frances A. "Teaching biotechnology in NSW schools /". View thesis View thesis, 1999. http://library.uws.edu.au/adt-NUWS/public/adt-NUWS20030901.124743/index.html.
Testo completoDEMONTIS, VALERIA. "Porous Silicon applications in biotechnology". Doctoral thesis, Università degli Studi di Cagliari, 2007. http://hdl.handle.net/11584/266040.
Testo completoSunderland, Naomi Louise. "Biotechnology as Media: A Critical Study of the Movement of Meanings Associated with Contemporary Biotechnology". Thesis, Queensland University of Technology, 2004. https://eprints.qut.edu.au/16705/1/Naomi_Sunderland_Thesis.pdf.
Testo completoSunderland, Naomi Louise. "Biotechnology as Media: A Critical Study of the Movement of Meanings Associated with Contemporary Biotechnology". Queensland University of Technology, 2004. http://eprints.qut.edu.au/16705/.
Testo completoWillrodt, Christian. "Synthetic biology for synthetic chemistry - Microbial production and selective functionalization of limonene". Doctoral thesis, Universitätsbibliothek Leipzig, 2016. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-201140.
Testo completoBondarew, Veronica. "Small firm growth in the Australian biotechnology industry a study of obstacles to the commercialisation of Australian biotechnology research /". Doctoral thesis, Australia : Macquarie University, 2007. http://hdl.handle.net/1959.14/22345.
Testo completoBibliography: p. 209-223.
Introduction -- The biotechnology industry -- Literature review -- Methodology -- Case studies -- Discussion -- Conclusion.
Australia has a strong record of medical science research. Of the country's seven Nobel Prize winners, six have been within the bioscience sector. But Australia has been struggling to produce an FDA-approved blockbuster drug. The high level of research output in biotechnology is inconsistent with the low level of commercialisation of products resulting from the research.-- What distinguishes the successful companies in the Australian biotechnology industry? In particular, what obstacles are encountered by Australian scientists attempting to commercialise their inventions and are these obstacles spicific to the Australian context? Biotechnology impacts on an extraordinary range of industries, particularly in the health care sector, and is one of the major drivers of sustainable economic growth in the 21st century. The contrast between the Australian biotechnology industry's potential and achievements inhibits its ability to contribute to national wealth. This study investigates the difficulties encountered by Australian biotechnology firms in their attempts to commercialise their research.-- Garnsey's (1998) small firm growth model, based on engineering firms with in-house production, has been used to identify obstacles to biotechnology innovation and problems encountered in commercialising the research before the firm has been established. The research question asks to what extent the model can assist in understanding the obstacles that impede the growth of Australian biotechnology firms.-- Taking a qualitative approach and using an integrated and coherent case study methodology, the research identifies major obstacles to the growth of five firms through three clearly identifiable phases. Findings from the comparative case study analysis show that the firms' growth patterns generally conform to the model, but with major deviations due to specific differences between the engineering and biotechnology industries, Although biotechnology firms worldwide face similar obstacles to their growth, Australian firms encounter additional problems that seriously impede potential commercialisation of their biotechnology research.
Mode of access: World Wide Web.
xiv, 378 p
Hui, Chak-hung Dickson. "Planning for high technology industry in Hong Kong : a case study of biotechnology industry /". Hong Kong : University of Hong Kong, 1994. http://sunzi.lib.hku.hk/hkuto/record.jsp?B14014567.
Testo completoJens, Paul Justin, e paul jens@csl com au. "Valuation Models for Australian Biotechnology Companies". RMIT University. Economics, Finance and Marketing, 2007. http://adt.lib.rmit.edu.au/adt/public/adt-VIT20080226.120515.
Testo completoKelly, Mary Theresa. "Frankenfood, risk and ritual in biotechnology". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape9/PQDD_0024/MQ47952.pdf.
Testo completoCamsund, Daniel. "Engineering Transcriptional Systems for Cyanobacterial Biotechnology". Doctoral thesis, Uppsala universitet, Molekylär biomimetik, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-223599.
Testo completoMartin, Helen. "Information flows in a biotechnology company". Thesis, Loughborough University, 2000. https://dspace.lboro.ac.uk/2134/13915.
Testo completoSpice, William Matthew. "Principles of process development in biotechnology". Thesis, University of Westminster, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328256.
Testo completoSkodbo, Sara. "Consuming biotechnology : innovation, regulation and resistance". Thesis, University College London (University of London), 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.402465.
Testo completoKristinsdottir, Asbjorg. "Capital project development in biotechnology industry". Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/44285.
Testo completoIncludes bibliographical references (p. 61-62).
The biotechnology industry has experienced fast growth during the first 30 years of its existence but is now reaching a stage of maturity. Companies are being challenged by weak pipelines and patent expirations, as well as increasing regulation. Mergers and acquisitions are frequent, and companies are forced to reduce planned capital expenditures, as well as restructure with personnel cuts and facility reductions. This thesis focuses on the affect those changes are having on the development of capital projects. It researches the environment as it used to be and what is now bringing the changes. Through literature search and case study, the thesis aims to capture the reasons for why the main driver of new facilities construction has shifted from time to cost and the affect that is having on the management and delivery of such projects.
by Asbjorg Kristinsdottir.
S.M.
Verspaget, Cynthia J. "Unruly Bodies: Monstrous Readings of Biotechnology". Thesis, Curtin University, 2015. http://hdl.handle.net/20.500.11937/1994.
Testo completoBroccanello, Chiara. "Biotechnology applications in sugar beet breeding". Doctoral thesis, Università degli studi di Padova, 2016. http://hdl.handle.net/11577/3424820.
Testo completoLo scopo della tesi è stato quello di identificare marcatori molecolari associati alla tolleranza a stress biotici e abiotici in barbabietola da zucchero. La barbabietola attualmente produce circa il 20% dello zucchero mondiale. Uno dei maggiori obiettivi del miglioramento genetico è lo sviluppo di varietà che richiedano un sempre più basso utilizzo di mezzi tecnici per la coltivazione. Per raggiungere questo scopo, il breeding della barbabietola si è focalizzato su programmi di miglioramento genetico assistito da marcatori molecolari. Queste tecniche stanno rendendo la procedura di selezione più rapida, precisa e meno costosa. Lo sviluppo di un ampio set di marcatori SNP (Single Nucleotide Polymorphism) può facilitare l’identificazione e l’utilizzo di geni che controllano caratteri importanti di resistenza agli stress biotici e abiotici. Molte sono le tecniche che vengono utilizzate per lo sviluppo di marcatori SNP nelle piante. Fra queste, la tecnica Restriction-site Associated DNA (RAD), impiegata nel presente lavoro di tesi, è ampiamente diffusa e si basa sull'acquisizione e la caratterizzazione di regioni genomiche adiacenti a siti di restrizione riconosciuti da specifici enzimi. E’ stata utilizzata anche l’analisi dei segreganti riuniti (BSA) per identificare marcatori del DNA legati a geni o a regioni genomiche di interesse. Nella prima parte della tesi è stato messo a punto un set di 192 SNP per la genotipizzazione ad alta processività di accessioni di barbabietola utilizzando una recente piattaforma (QuantStudio 12K Flex system) rilasciata da Life Technologies, Inc. (Carlsbad, CA, USA). Nella seconda parte della tesi i 192 SNP sono stati utilizzati per determinare la relazione filogenetica tra le due fonti di resistenza alla rizomania Rizor e Holly (Rz1). L’analisi della varianza e delle componenti principali hanno confermato che le fonti Rizor e Holly sono indistinguibili. I risultati molecolari hanno dimostrato che la resistenza usata, dai coltivatori negli ultimi 30 anni, deriva dalle barbabietole maritime collezionate nel delta del Po. Nella terza parte è stato identificato il primo gene di tolleranza ai nematodi (HsBvm-1) in Beta vulgaris spp. maritima e il marcatore molecolare ad esso associato da utilizzare in programmi di miglioramento genetico. La quarta e quinta parte sono state focalizzate sulla resistenza a stress abiotici che compromettono la produzione di zucchero. La tendenza alla prefioritura, dovuta alle basse temperature nelle prime fasi di sviluppo della coltura, è una caratteristica indesiderata che causa gravi perdite nella resa di zucchero e interferisce con la raccolta. Un nuovo locus, implicato nel controllo genetico della tendenza alla fioritura, assieme a un marcatore ad esso legato sono stati mappati sul cromosoma 6. La localizzazione dello SNP sul genoma di riferimento della barbabietola da zucchero ha confermato l’associazione con il carattere della fioritura. Lo SNP è stato mappato in un gene che codifica per una proteina chiamata metalloproteinasi che causa un ritardo della fioritura e una prematura senescenza in Arabidopsis thaliana. Data la positiva e stretta relazione tra la resa in zucchero, il superamento della carenza idrico nutrizionale e le caratteristiche morfo-fisiologiche dell’apparato radicale, un’analisi dei segreganti riuniti è stata condotta per identificare marcatori SNP legati all'accrescimento radicale in barbabietola. Fra i 234 SNP esaminati, lo SNP10139 è risultato associato allo sviluppo radicale. Inoltre, lo SNP è stato mappato in un gene codificante un trasportatore di peptidi che influenza lo sviluppo radicale in Arabidopsis thaliana. In conclusione, gli SNP sviluppati in questo lavoro saranno utilizzati per la genotipizzazione di linee parentali e ibridi di barbabietola da zucchero, con rilevante impatto nei programmi di breeding.
Loh, Melvyn Wei Ming. "Riding the biotechnology wave : a mixed-methods analysis of Malaysia's emerging biotechnology industry : a thesis submitted to the Victoria University of Wellington in fulfilment of the requirements for the degree of Master of Commerce and Administration in Management /". ResearchArchive@Victoria e-thesis, 2009. http://hdl.handle.net/10063/963.
Testo completoPorter, Jean Nicole. "A descriptive study of agriculture teachers' awareness of biotechnology and the future of biotechnology education in Illinois /". Available to subscribers only, 2007. http://proquest.umi.com/pqdweb?did=1328062471&sid=30&Fmt=2&clientId=1509&RQT=309&VName=PQD.
Testo completoDuru, Godwin Chukwunenye. "Biotechnology research in Nigeria : a socioeconomic analysis of the organization of agricultural research system's response to biotechnology /". The Ohio State University, 1988. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487596307359591.
Testo completoMinnella, Walter Settimo Leonardo. "Development of microfluidic tools for biological applications". Thesis, Bordeaux, 2017. http://www.theses.fr/2017BORD0664.
Testo completoThe topic of this manuscript is the development of microdevices, based on "lab on chip" (LOC) technology, aimed to the environmental control and regulation of biological systems for macro and microbiological applications. Indeed, microfluidics possesses some inherent features which allow the manipulation of the environment at the cell and sub-cell level which are superior than the degree of control achievable with standard techniques. In this thesis work the possibility to leverage these features to develop inexpensive yet effective diagnostic tools is explored. In particular, we report the development of microfluidic systems which allow seamless and fast media perfusion and a novel LOC platform capable of performing highly multiplexed real-time PCR assays. Concerning the microfluidic perfusion systems, the aim was to achieve in-flow substitution of the particles' surrounding media in order to enhance the separation capabilities of the coupled microfluidic sorting modules. The effectiveness of our approach was validated by obtaining high separation purities (>90%) using our microfluidic perfusion system coupled with an acoustophoresis chip to discern two population of micro-sized beads. Moreover, we conceived and developed a microfluidic thermalisation system capable of sub-second temperature switches. Specifically, this platform relies on conductive heat exchange between a thermalisation liquid flowing inside a microfluidic chip and the biological sample. These thermalisation performances, and the high surface to volume ratio typical of microfluidic devices, allowed to perform 50 qPCR cycles and subsequent melting curve analysis in less than ten minutes
Niemir, Natalia. "Gene transfer in the Sandhoff murine model using a specific recombinant AAV9 vector". Thesis, Paris 5, 2013. http://www.theses.fr/2013PA05S024/document.
Testo completoKamínková, Petra. "Geneticky modifikované plodiny v politice a právu Evropské unie". Master's thesis, Vysoká škola ekonomická v Praze, 2009. http://www.nusl.cz/ntk/nusl-17536.
Testo completoVusovic, Slavica. "State level location determinants for biotechnology firms". abstract and full text PDF (free order & download UNR users only), 2006. http://0-gateway.proquest.com.innopac.library.unr.edu/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:1438936.
Testo completoZucarelli, Michael, e Maurice Shauffert. "Profitability, Volatility, and Risk in the Biotechnology Sector". The University of Arizona, 2010. http://hdl.handle.net/10150/623904.
Testo completoOBJECTIVES: (1) To characterize the long-term performance of the biotechnology sector and the overall market using a Sharpe Ratio analysis (excess return/volatility; α/SD). The null hypothesis tested in this paper is the generalized Sharpe ratio characteristic of the biotechnology sector is identical to that of the overall market. METHODS: 337 companies were identified using Standard Industry Classification code 2836 (Biological Products, (No Diagnostic Substances)) lists from the Center for Research and Security Prices (CRSP) and S&P CompuStat databases. Market data on equity and return were derived from securities price data from the CRSP database. Market data were used to characterize the following measures: Mean Excess Return, Mean Excess Return minus 1% of top earners (trimmed), Volatility (SD),Sharpe Ratio and 1% Adjustment RESULTS: The study finds the biotech industry earned excess returns of 13.84% over time when compared to the overall market ( 5.10%). However, these returns are highly concentrated: When the top 1% of sector earners are removed from analysis, excess return declines below the risk free rate (return of -0.05%) suggesting significant barriers to risk diversification. CONCLUSIONS: The results show the biotechnology sector experiences higher volatility compared with the overall market, as well as higher excess returns. The results justify a rejection of the null hypothesis – that the generalized Sharpe ratio of the biotechnology sector is identical to that of the overall market
TAKABE, Tetsuko. "Biotechnology of Crop Production and International Consortium". 名古屋大学農学国際教育協力研究センター, 2004. http://hdl.handle.net/2237/8933.
Testo completoElshawadfy, Ashraf Mohamed. "Engineering archaeal DNA polymerases for biotechnology applications". Thesis, University of Newcastle Upon Tyne, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.606814.
Testo completoMoula, Payam. "Ethical aspects of crop biotechnology in agriculture". Licentiate thesis, KTH, Filosofi, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-162187.
Testo completoQC 20150330
Mistra Biotech
Stokes, Kathryn L. "A technology assessment of biotechnology in Ghana". Thesis, University of Strathclyde, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401310.
Testo completoVerre, Andrea Francesco. "Chemical modifications of graphene for biotechnology applications". Thesis, University of Manchester, 2017. https://www.research.manchester.ac.uk/portal/en/theses/chemical-modifications-of-graphene-for-biotechnology-applications(be403064-aa49-4bcf-a6dc-a3807b179644).html.
Testo completoValencia, Suarez Julio Enrique. "Development of tools for biotechnology of microalgae". Thesis, University of Manchester, 2014. https://www.research.manchester.ac.uk/portal/en/theses/development-of-tools-for-biotechnology-of-microalgae(b94627d0-c6c0-4055-bbaf-06e9cb9c565e).html.
Testo completoCupples, Gemma. "Fibre-laden flows in biology and biotechnology". Thesis, University of Birmingham, 2018. http://etheses.bham.ac.uk//id/eprint/8308/.
Testo completo